- Home
- RLAY vs CLMT Comparison
RLAY vs CLMT Comparison
Compare RLAY & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- CLMT
- Stock Information
- Founded
- RLAY 2015
- CLMT 1916
- Country
- RLAY United States
- CLMT United States
- Employees
- RLAY N/A
- CLMT N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- CLMT Oil & Gas Production
- Sector
- RLAY Health Care
- CLMT Energy
- Exchange
- RLAY Nasdaq
- CLMT Nasdaq
- Market Cap
- RLAY 1.1B
- CLMT 1.2B
- IPO Year
- RLAY 2020
- CLMT 2006
- Fundamental
- Price
- RLAY $5.11
- CLMT $20.80
- Analyst Decision
- RLAY Strong Buy
- CLMT Strong Buy
- Analyst Count
- RLAY 9
- CLMT 4
- Target Price
- RLAY $20.88
- CLMT $24.00
- AVG Volume (30 Days)
- RLAY 1.3M
- CLMT 739.7K
- Earning Date
- RLAY 11-06-2024
- CLMT 11-08-2024
- Dividend Yield
- RLAY N/A
- CLMT N/A
- EPS Growth
- RLAY N/A
- CLMT N/A
- EPS
- RLAY N/A
- CLMT N/A
- Revenue
- RLAY $10,006,000.00
- CLMT $4,216,399,999.00
- Revenue This Year
- RLAY N/A
- CLMT N/A
- Revenue Next Year
- RLAY N/A
- CLMT $6.99
- P/E Ratio
- RLAY N/A
- CLMT N/A
- Revenue Growth
- RLAY N/A
- CLMT 0.30
- 52 Week Low
- RLAY $5.03
- CLMT $9.97
- 52 Week High
- RLAY $12.14
- CLMT $25.29
- Technical
- Relative Strength Index (RSI)
- RLAY 28.59
- CLMT 51.58
- Support Level
- RLAY $5.96
- CLMT $19.61
- Resistance Level
- RLAY $6.39
- CLMT $22.84
- Average True Range (ATR)
- RLAY 0.36
- CLMT 1.36
- MACD
- RLAY -0.04
- CLMT -0.16
- Stochastic Oscillator
- RLAY 5.10
- CLMT 55.58
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.